Clinical Trial Update: TevaGastrim for Stem Cell Mobilization Sibling Donors [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports the completion of a study evaluating TevaGastrim for stem cell mobilization in sibling donors for acute myeloid leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• TevaGastrim (filgrastim)

Snippet

Sponsor: Sheba Medical Center | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED